Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma by Biopsy Specimens.

NCT06490003 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT06490003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06490003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma by Biopsy Specimens.
Lead sponsor
City of Hope Medical Center
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2004
Completion date
June 18, 2028
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy effect, dna methylation, esophageal squamous cell carcinoma